Advancing nucleic acid therapeutics with circular RNA

Exploring advances in bioconjugation: nanozymes, tissue tropism, and the future of responsive systems

The promise of antibody-oligonucleotide conjugates for neurological diseases

From innovation to access: bridging gaps in scalability and cold chain precision logistics for advanced therapies

Enhancing mRNA results through strategic RNA design and quality control

For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications

Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space

Driving innovation in cell and gene therapy: the role of AI and robotics

Spatial mapping: shaping the future of I-O diagnostics and treatment

Pioneering quality control in biomanufacturing of cell and gene therapies

Preparing for tomorrow’s cell and gene therapies today: lessons from 30 years in the field

Insights into advanced therapies in the context of evolving funding and M&A environments

Fit for function: developing potency assays reflective of the in vivo environment

Gene therapy is having a monumental year: how can the industry keep up with supply?

A deep dive in to generative AI applications in I-O

Developing novel radioimmunotherapy combinations for lung cancer treatment

Focusing on the fundamentals: what do and don’t we know about mRNA delivery?

Navigating genomics and transcriptomics in the immuno-oncology space

Avian influenza and the risk of pandemic

Exploring the landscape of novel targets & pathways in immuno-oncology